PortfoliosLab logoPortfoliosLab logo
DHR vs. RMD
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Performance

DHR vs. RMD - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Danaher Corporation (DHR) and ResMed Inc. (RMD). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

DHR vs. RMD - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
DHR
Danaher Corporation
-17.00%0.35%-0.35%-1.22%-19.02%48.57%45.34%49.55%11.80%20.01%
RMD
ResMed Inc.
-6.59%6.26%34.18%-16.55%-19.47%23.41%38.33%37.85%36.38%39.06%

Fundamentals

EPS

DHR:

$5.06

RMD:

$15.16

PE Ratio

DHR:

37.49

RMD:

14.81

PS Ratio

DHR:

5.51

RMD:

4.08

Total Revenue (TTM)

DHR:

$24.57B

RMD:

$5.40B

Gross Profit (TTM)

DHR:

$14.97B

RMD:

$3.29B

EBITDA (TTM)

DHR:

$7.02B

RMD:

$1.96B

Returns By Period

In the year-to-date period, DHR achieves a -17.00% return, which is significantly lower than RMD's -6.59% return. Over the past 10 years, DHR has underperformed RMD with an annualized return of 12.00%, while RMD has yielded a comparatively higher 15.62% annualized return.


DHR

1D
3.11%
1M
-9.80%
YTD
-17.00%
6M
-4.03%
1Y
-6.87%
3Y*
-4.81%
5Y*
-0.55%
10Y*
12.00%

RMD

1D
2.02%
1M
-12.40%
YTD
-6.59%
6M
-17.61%
1Y
1.18%
3Y*
1.78%
5Y*
3.81%
10Y*
15.62%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

DHR vs. RMD — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

DHR
DHR Risk / Return Rank: 3030
Overall Rank
DHR Sharpe Ratio Rank: 3232
Sharpe Ratio Rank
DHR Sortino Ratio Rank: 2828
Sortino Ratio Rank
DHR Omega Ratio Rank: 2929
Omega Ratio Rank
DHR Calmar Ratio Rank: 3333
Calmar Ratio Rank
DHR Martin Ratio Rank: 2727
Martin Ratio Rank

RMD
RMD Risk / Return Rank: 4141
Overall Rank
RMD Sharpe Ratio Rank: 4444
Sharpe Ratio Rank
RMD Sortino Ratio Rank: 3737
Sortino Ratio Rank
RMD Omega Ratio Rank: 3636
Omega Ratio Rank
RMD Calmar Ratio Rank: 4545
Calmar Ratio Rank
RMD Martin Ratio Rank: 4646
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

DHR vs. RMD - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Danaher Corporation (DHR) and ResMed Inc. (RMD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


DHRRMDDifference

Sharpe ratio

Return per unit of total volatility

-0.21

0.05

-0.26

Sortino ratio

Return per unit of downside risk

-0.09

0.26

-0.34

Omega ratio

Gain probability vs. loss probability

0.99

1.03

-0.04

Calmar ratio

Return relative to maximum drawdown

-0.29

0.12

-0.41

Martin ratio

Return relative to average drawdown

-0.87

0.28

-1.15

DHR vs. RMD - Sharpe Ratio Comparison

The current DHR Sharpe Ratio is -0.21, which is lower than the RMD Sharpe Ratio of 0.05. The chart below compares the historical Sharpe Ratios of DHR and RMD, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


DHRRMDDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.21

0.05

-0.26

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.02

0.12

-0.14

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.48

0.50

-0.02

Sharpe Ratio (All Time)

Calculated using the full available price history

0.65

0.53

+0.12

Correlation

The correlation between DHR and RMD is 0.33, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

DHR vs. RMD - Dividend Comparison

DHR's dividend yield for the trailing twelve months is around 0.72%, less than RMD's 1.04% yield.


TTM20252024202320222021202020192018201720162015
DHR
Danaher Corporation
0.72%0.56%0.47%12.64%0.38%0.26%0.32%0.44%0.62%0.60%32.55%0.58%
RMD
ResMed Inc.
1.04%0.94%0.88%1.07%0.83%0.62%0.73%0.98%1.26%1.61%2.03%2.16%

Drawdowns

DHR vs. RMD - Drawdown Comparison

The maximum DHR drawdown since its inception was -45.80%, smaller than the maximum RMD drawdown of -61.61%. Use the drawdown chart below to compare losses from any high point for DHR and RMD.


Loading graphics...

Drawdown Indicators


DHRRMDDifference

Max Drawdown

Largest peak-to-trough decline

-45.80%

-61.61%

+15.81%

Max Drawdown (1Y)

Largest decline over 1 year

-24.85%

-24.74%

-0.11%

Max Drawdown (5Y)

Largest decline over 5 years

-39.81%

-53.99%

+14.18%

Max Drawdown (10Y)

Largest decline over 10 years

-39.81%

-53.99%

+14.18%

Current Drawdown

Current decline from peak

-34.20%

-23.22%

-10.98%

Average Drawdown

Average peak-to-trough decline

-10.08%

-15.91%

+5.83%

Ulcer Index

Depth and duration of drawdowns from previous peaks

8.34%

10.55%

-2.21%

Volatility

DHR vs. RMD - Volatility Comparison

Danaher Corporation (DHR) has a higher volatility of 8.93% compared to ResMed Inc. (RMD) at 6.17%. This indicates that DHR's price experiences larger fluctuations and is considered to be riskier than RMD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


DHRRMDDifference

Volatility (1M)

Calculated over the trailing 1-month period

8.93%

6.17%

+2.76%

Volatility (6M)

Calculated over the trailing 6-month period

20.17%

17.04%

+3.13%

Volatility (1Y)

Calculated over the trailing 1-year period

32.45%

25.62%

+6.83%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

27.75%

31.07%

-3.32%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

25.24%

31.41%

-6.17%

Financials

DHR vs. RMD - Financials Comparison

This section allows you to compare key financial metrics between Danaher Corporation and ResMed Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.002.00B4.00B6.00B8.00B20212022202320242025
6.84B
1.42B
(DHR) Total Revenue
(RMD) Total Revenue
Values in USD except per share items

DHR vs. RMD - Profitability Comparison

The chart below illustrates the profitability comparison between Danaher Corporation and ResMed Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

54.0%56.0%58.0%60.0%62.0%64.0%66.0%20212022202320242025
58.0%
61.8%
Portfolio components
DHR - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Danaher Corporation reported a gross profit of 3.97B and revenue of 6.84B. Therefore, the gross margin over that period was 58.0%.

RMD - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, ResMed Inc. reported a gross profit of 878.72M and revenue of 1.42B. Therefore, the gross margin over that period was 61.8%.

DHR - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Danaher Corporation reported an operating income of 1.50B and revenue of 6.84B, resulting in an operating margin of 22.0%.

RMD - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, ResMed Inc. reported an operating income of 491.66M and revenue of 1.42B, resulting in an operating margin of 34.6%.

DHR - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Danaher Corporation reported a net income of 1.20B and revenue of 6.84B, resulting in a net margin of 17.5%.

RMD - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, ResMed Inc. reported a net income of 392.59M and revenue of 1.42B, resulting in a net margin of 27.6%.